Thursday 22 April 2021
Home      All news      Contact us      RSS      India
ndtv.com - 2 month ago

Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech

Phase 3 results for Bharat Biotech s coronavirus vaccine - Covaxin - were released Wednesday afternoon, with the drug demonstrating 81 per cent interim efficacy in preventing COVID-19 in those...


Latest News
Hashtags:   

Covaxin

 | 

Shows

 | 

Interim

 | 

Efficacy

 | 

Phase

 | 

Results

 | 

Bharat

 | 

Biotech

 | 

Sources